Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award President and CEO acquired 226,300 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 211,190 shares at $2.99 ($631,099)
  7. 4 Open-market sale Chief Medical Officer sold 4,083 shares at $2.99 ($12,196)
  8. 4 Open-market sale Chief Scientific Officer sold 4,370 shares at $2.99 ($13,053)
  9. 4 Open-market sale Chief Operations Officer sold 4,370 shares at $2.99 ($13,053)
  10. 4 Open-market sale President and CEO sold 17,196 shares at $2.99 ($51,363)
  11. 4 Open-market buy Director bought 3,821,273 shares at an average $3.06 ($11,687,810)
  12. 4 Grant or award Chief Medical Officer acquired 13,750 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 13,750 shares (grant or award)
  14. 4 Grant or award Chief Operations Officer acquired 13,750 shares (grant or award)
  15. 4 Grant or award President and CEO acquired 37,500 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.03 ($15,127)
  17. 4 Open-market buy Director bought 7,000 shares at $2.96 ($20,723)
  18. 4 Open-market buy Director bought 17,200 shares at $2.95 ($50,664)
  19. 4 Open-market sale President and CEO sold 4,746 shares at $2.96 ($14,065)
  20. 4 Open-market sale Chief Medical Officer sold 3,636 shares at $4.39 ($15,962)

Page 9 of 21 · 410 filings